| Literature DB >> 24082148 |
Mohamed Ali Ibrahim1, MinKyun Na, Joonseok Oh, Raymond F Schinazi, Tami R McBrayer, Tony Whitaker, Robert J Doerksen, David J Newman, Louis G Zachos, Mark T Hamann.
Abstract
One in five of the world's plant species is threatened with extinction according to the 2010 first global analysis of extinction risk. Tilman et al. predicted a massive ecological change to terrestrial plants within the next 50-100 y, accompanied by an increase in the number of global plant species facing extinction [Tilman D, et al. (2001) Proc Natl Acad Sci USA 98(10):5433-5440]. Most of the drug-producing plant families contain endangered species never previously studied for their utility to human health, which strongly validates the need to prioritize protection and assessment of these fragile and endangered groups [Zhu F, et al. (2011) Proc Natl Acad Sci USA 108(31):12943-12948]. With little prior attention given to endangered and rare plant species, this report provides strong justification for conservation of the rare plant Diplostephium rhododendroides Hieron., as well as other potential drug-producing endangered species in this and other groups.Entities:
Keywords: diabetes mellitus; endangered plants; hepatitis C virus
Mesh:
Year: 2013 PMID: 24082148 PMCID: PMC3801070 DOI: 10.1073/pnas.1311528110
Source DB: PubMed Journal: Proc Natl Acad Sci U S A ISSN: 0027-8424 Impact factor: 11.205